Searched for
DIABETIC MACULAR EDEMA
Small-cap stocks: Riskier, without a doubt. But time to be contrarian? 6 small-caps from different sectors to keep an eye onWhy look at small-caps when there are many large-cap stocks available at decent valuations? But then, a counter-question: When is it a good...- For impatient investors with the ability to be patient for 3 years: 5 small-caps from 4 different growth sectors that fit the billIn an emerging economy, how to define a growth sector? It is an industry whose real value added grows persistently above the national GDP g...
- For those with a 3- to 5-year investing perspective: 5 small-caps, 3 with an upside potential of up to 63%There are some sectors where the opportunity is so large that there is a high probability that even a small-cap company can grow in size. J...
- Lupin ties up with Sandoz to commercialise biosimilar productLupin has partnered with Sandoz Group AG to commercialize its biosimilar ranibizumab across multiple regions, with Sandoz handling commerci...
- Lupin inks licensing deal to supply biosimilar ranibizumab in Latin AmericaLupin, an Indian drug maker, partners with SteinCares. The agreement focuses on ranibizumab's commercialisation. Latin America, excluding M...
- Small caps: Correction and volatility are temporary noises if underlying business is fine. 5 small-caps stocks for a long-term investorThe last quarter of 2024 is turning out to be the opposite of 2023’s last quarter. Around this time last year, there was a mad rush to buy ...
- A bit of hard work goes a long way in giving a return: 5 small caps stocks which tick the right boxesLike other parts of the markets, even the small cap space is witnessing profit booking, but this time it is more orderly as compared to pas...
- Roche launches top selling eye drug Vabysmo in IndiaRoche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The...
- Lupin ties up with Amman Pharma for commercialisation of biosimilar productLupin has inked a licensing pact for the commercialisation and marketing of Ranibizumab, a biosimilar of Lucentis, in various countries inc...
- Bayer steps up India R&D, clinical trials"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...
- Diabetic retinopathy explained: From eye exams to dietary changes, here's how to keep your eyes healthyAs many as 6.9 per cent of people with diabetes in India have been diagnosed with DR.
- Shilpa Medicare arm gets NoC to conduct clinical studies for its Biosimilar AfliberceptListed pharmaceutical entity Shilpa Medicare on Monday informed the exchanges that its subsidiary Shilpa Biologicals (SBPL) has received a ...
- Bayer's Aflibercept injection gets DCGI nod for Diabetic Macular Edema indicationDiabetic Macular Edema occurs when high blood sugar levels damage capillaries that leak fluid into the retina, resulting in swelling and bl...
- Do you experience flashes of light, distortion of images, cloudy vision? Screening for retinal diseases early can be beneficialIt is important for everyone to detect drop in vision at the earliest stage.
- New technique for early detection of human eye diseasesKolkata, Dec 27 (IANS) A software analysis can now highlight the subtle differences between a diseased and healthy retina, a development th...
- Smartphones to detect eye diseasesA new software that can detect eye diseases by making use of the smartphone camera has been developed.
- Sun & Intrexon JV for ocular diseasesThe joint venture will leverage Sun Pharma's global capabilities and experience in developing and manufacturing complex dosage forms and sp...
Load More
